Furthermore, the NLRP3 inflammasome also serves as a mediator of NETosis and thrombosis, highlighting the importance of NLRP3 inhibition as a novel therapeutic approach for thrombotic diseases [98]. Here, NLRP3 is linked to thrombotic disease.